399 related articles for article (PubMed ID: 16146157)
1. [Attention deficit hyperactivity disorder: pharmacological options that are not "Ritalin"].
Shmueli D; Gross-Tsur V
Harefuah; 2005 Aug; 144(8):572-6, 597. PubMed ID: 16146157
[TBL] [Abstract][Full Text] [Related]
2. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
3. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
4. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
6. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
Heal DJ; Cheetham SC; Smith SL
Neuropharmacology; 2009 Dec; 57(7-8):608-18. PubMed ID: 19761781
[TBL] [Abstract][Full Text] [Related]
7. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.
Prince JB
Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):13-50. PubMed ID: 16321724
[TBL] [Abstract][Full Text] [Related]
9. New options in the pharmacological management of attention-deficit/hyperactivity disorder.
Olfson M
Am J Manag Care; 2004 Jul; 10(4 Suppl):S117-24. PubMed ID: 15352538
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
[TBL] [Abstract][Full Text] [Related]
11. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
Sasané R; Hodgkins P; Meijer W
Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
[TBL] [Abstract][Full Text] [Related]
12. [Attention deficit hyperactivity disorder in adults: a clinical and therapeutic characterization].
Ramos-Quiroga JA; Bosch-Munsó R; Castells-Cervelló X; Nogueira-Morais M; García-Gimenez E; Casas-Brugué M
Rev Neurol; 2006 May 16-31; 42(10):600-6. PubMed ID: 16703528
[TBL] [Abstract][Full Text] [Related]
13. Collicular dysfunction in attention deficit hyperactivity disorder.
Overton PG
Med Hypotheses; 2008; 70(6):1121-7. PubMed ID: 18215471
[TBL] [Abstract][Full Text] [Related]
14. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
Wang Y; Zheng Y; Du Y; Song DH; Shin YJ; Cho SC; Kim BN; Ahn DH; Marquez-Caraveo ME; Gao H; Williams DW; Levine LR
Aust N Z J Psychiatry; 2007 Mar; 41(3):222-30. PubMed ID: 17464703
[TBL] [Abstract][Full Text] [Related]
16. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
Harpin VA
Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
[TBL] [Abstract][Full Text] [Related]
17. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
18. [Utilization of methylphenidate(Ritalin) in France].
Frances C; Hoizey G; Millart H; Trenque T
Therapie; 2002; 57(2):189-93. PubMed ID: 12185970
[TBL] [Abstract][Full Text] [Related]
19. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
20. Dexmethylphenidate for attention deficit hyperactivity disorder.
Coury D
Expert Opin Pharmacother; 2009 Nov; 10(16):2679-85. PubMed ID: 19874250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
